Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04060394
Title Dose-Escalation and Efficacy Study of LAE001/Prednisone Plus Afuresertib Patients With m-CRPC
Recruitment Completed
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Laekna Limited
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Urological Associates of Southern Arizona Tucson Arizona 85741 United States Details
California Cancer Associates for Researh & Excellence, Inc Encinitas California 92024 United States Details
Eastern Connnecticut Hematology/Oncology Associates Norwich Connecticut 06360 United States Details
Piedmont Columbus Regional Research Institute Columbus Georgia 31901 United States Details
University of Chicago Chicago Illinois 60637 United States Details
Cotton-O'Neil Clinical Research Center Topeka Kansas 66606 United States Details
Associated Medical Professionals of NY Syracuse New York 13215 United States Details
Oregon Urology Institute Florence Oregon 97439 United States Details
Greenville Hospital System Greenville South Carolina 29605 United States Details
Mary Crowley Cancer Research Centers Dallas Texas 75251 United States Details
Baylor Scott and White Health Temple Texas 76508 United States Details
Northwest Medical Specialties, PLLC Tacoma Washington 98405 United States Details
National Cancer Center Goyang-si Gyeonggido 10408 Korea, Republic of Details
Seoul National University Bundang Hospital Seongnam-si Gyunggido 13605 Korea, Republic of Details
Seoul National University Hospital Seoul 03080 Korea, Republic of Details
Severance Hospital Seoul 03722 Korea, Republic of Details
Asan Medical Center Seoul 05505 Korea, Republic of Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field